FDA — authorised 9 April 2025
- Application: BLA761175
- Marketing authorisation holder: BIOCON BIOLOGICS INC
- Local brand name: JOBEVNE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 JOBEVNE in United States
FDA authorised JOBEVNE on 9 April 2025
Marketing authorisation
JOBEVNE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is JOBEVNE approved in United States?
Yes. FDA authorised it on 9 April 2025.
Who is the marketing authorisation holder for JOBEVNE in United States?
BIOCON BIOLOGICS INC holds the US marketing authorisation.